High-throughput genotyping of Plasmodium vivax in the Peruvian Amazon via molecular inversion probes
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This has led to them being increasingly adopted by research teams and national malaria control programmes (NMCPs) [13,14,17].”
From Plasmodium vivax relapse reservoirs in Ethiopia: microhaplotype sequencing informs recurrent infection origins (2026) · cites this paper as [17]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Plasmodium falciparum resistant to artemisinin and diagnostics have emerged in Ethiopia
Fola, A. A., Feleke, S. M., Mohammed, H., Brhane, B. G., Hennelly, C. M., Assefa, A., Crudal, R. M., Reichert, E., Juliano, J. J., Cunningham, J., et al. (2023) · Nature Microbiology · doi:10.1038/s41564-023-01461-4 · Cited by 213
Self-citationOzodiegwu, I. D., Ambrose, M., Battle, K. E., Bever, C., Diallo, O., Galatas, B., Runge, M., & Gerardin, J. (2021) · Malaria Journal · doi:10.1186/s12936-021-03646-w · Cited by 64
Benavente, E. D., Oresegun, D. R., de Sessions, P. F., Walker, E. M., Roper, C., Dombrowski, J. G., de Souza, R. M., Marinho, C. R. F., Sutherland, C. J., Hibberd, M. L., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-33767-3 · Cited by 47 · cited 1×
“The implications of the CNV we detected in 14 isolates are somewhat unclear, but may suggest that vaccines targeting DBP or the RBPs that do not account for this variability may have reduced ef fi cacy 58 .”
Siegel, S. V., Trimarsanto, H., Amato, R., Murie, K., Taylor, A. R., Sutanto, E., Kleinecke, M., Whitton, G., Watson, J. A., Imwong, M., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-51015-3 · Cited by 30
Research works printed but not linked: 67
- Battle, K. E. & Baird, J. K. The global burden of Plasmodium vivax malaria is obscure and insidious. PLoS Med. 18, e1003799 (2021). · DOI
- Commons, R. J., Simpson, J. A., Watson, J., White, N. J. & Price, R. N. Estimating the proportion of plasmodium vivax recurrences caused by relapse: a systematic review and meta-analysis. Am. J. Trop. Med. Hyg. 103, 1094–1099 (2020). · DOI · Paper page
- Bousema, T. & Drakeley, C. Epidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax Gametocytes in relation to malaria control and elimination. Clin. Microbiol Rev. 24, 377–410 (2011). · DOI · Paper page
- Tarimo, B. B. et al. Seasonality and transmissibility of Plasmodium ovale in Bagamoyo District, Tanzania. Parasit. Vectors 15, 56 (2022). · doi:10.1186/s13071-022-05181-2
- Quah, Y. W. et al. Molecular epidemiology of residual Plasmodium vivax transmission in a paediatric cohort in Solomon Islands. Malar. J. 18, 106 (2019). · DOI
- Brazeau, N. F. et al. The epidemiology of Plasmodium vivax among adults in the Democratic Republic of the Congo. Nat. Commun. 12, 1–10 (2021). · DOI
- Zhong, D. et al. Multiplicity and molecular epidemiology of Plasmodium vivax and Plasmodium falciparum infections in East Africa. Malar. J. 17, 185 (2018). · DOI
- Pearson, R. D. et al. Genomic analysis of local variation and recent evolution in Plasmodium vivax. Nat. Genet. 48, 959–964 (2016). · DOI · Paper page
- Popovici, J. et al. Genomic analyses reveal the common occurrence and complexity of Plasmodium vivax relapses in Cambodia. mBio 9, e01888–17 (2018). · DOI
- Auburn, S. et al. Genomic analysis of Plasmodium vivax in southern Ethiopia reveals selective pressures in multiple parasite mechanisms. J. Infect. Dis. 220, 1738–1749 (2019). · DOI
- Valdivia, H. O. et al. Genomic surveillance of Plasmodium falciparum and Plasmodium vivax cases at the University Hospital in Tegucigalpa, Honduras. Sci. Rep. 10, 20975 (2020). · DOI
- Gartner, V. et al. Genomic insights into Plasmodium vivax population structure and diversity in central Africa. Malar. J. 23, 1–9 (2024). · DOI
- Brashear, A. M. et al. Population genomics identifies a distinct Plasmodium vivax population on the China-Myanmar border of Southeast Asia. PLoS Negl. Trop. Dis. 14, e0008506 (2020). · DOI
- Ibrahim, A. et al. Population-based genomic study of Plasmodium vivax malaria in seven Brazilian states and across South America. Lancet Reg. Health - Am. 18, 100420 (2023).
- Auburn, S. et al. Genomic analysis of a pre-elimination Malaysian Plasmodium vivax population reveals selective pressures and changing transmission dynamics. Nat. Commun. 9, 1–12 (2018). · DOI · Paper page
- Cowell, A. N., Valdivia, H. O., Bishop, D. K. & Winzeler, E. A. Exploration of Plasmodium vivax transmission dynamics and recurrent infections in the Peruvian Amazon using whole genome sequencing. Genome Med. 10, 1–12 (2018). · DOI · Paper page
- Kattenberg, J. H. et al. Plasmodium vivax genomic surveillance in the Peruvian Amazon with Pv AmpliSeq assay. PLoS Negl. Trop. Dis. 18, e0011879 (2024). · DOI
- Moser, K. A. et al. Describing the current status of Plasmodium falciparum population structure and drug resistance within mainland Tanzania using molecular inversion probes. Mol. Ecol. 30, 100–113 (2021). · DOI
- Verity, R. et al. The impact of antimalarial resistance on the genetic structure of Plasmodium falciparum in the DRC. Nat. Commun. 11, 2107 (2020). · DOI
- Mensah, B. A. et al. Antimalarial drug resistance profiling of Plasmodium falciparum infections in Ghana using molecular inversion probes and next-generation sequencing. Antimicrob. Agents Chemother. 64, e01423–19 (2020). · DOI
- MalariaGEN Plasmodium falciparum Community Project. Genomic epidemiology of artemisinin resistant malaria. Elife 5, e08714 (2016). · DOI · Paper page
- Neafsey, D. E. et al. The malaria parasite Plasmodium vivax exhibits greater genetic diversity than Plasmodium falciparum. Nat. Genet 44, 1046–1050 (2012). · DOI · Paper page
- Huang, F. et al. Genomic epidemiology of antimalarial drug resistance in Plasmodium falciparum in Southern China. Front Cell Infect. Microbiol 10, 610985 (2021). · doi:10.3389/fcimb.2020.610985
- Coonahan, E. et al. Whole-genome surveillance identifies markers of Plasmodium falciparum drug resistance and novel genomic regions under selection in Mozambique. mBio 14, e0176823 (2023). · DOI
- Talundzic, E. et al. Molecular epidemiology of Plasmodium falciparum kelch13 mutations in Senegal determined by using targeted amplicon deep sequencing. Antimicrob. Agents Chemother. 61, e02116 (2017). · DOI
- Feleke, S. M. et al. Plasmodium falciparum is evolving to escape malaria rapid diagnostic tests in Ethiopia. Nat. Microbiol. 6, 1289–1299 (2021). · DOI · Paper page
- Parker, B. S. et al. Hyperendemic malaria transmission in areas of occupation-related travel in the Peruvian Amazon. Malar. J. 12, 1–15 (2013). · DOI · Paper page
- Sanchez-Castro, E. E. et al. Health and economic burden due to malaria in Peru over 30 years (1990–2019): Findings from the global burden of diseases study 2019. Lancet Reg. Health - Am. 15, 100347 (2022).
- Carrasco-Escobar, G. et al. Micro-epidemiology and spatial heterogeneity of P. vivax parasitaemia in riverine communities of the Peruvian Amazon: a multilevel analysis. Sci. Rep. 7, 1–17 (2017). · DOI
- Carrasco-Escobar, G. et al. High prevalence of very-low Plasmodium falciparum and Plasmodium vivax parasitaemia carriers in the Peruvian Amazon: insights into local and occupational mobility-related transmission. Malar. J. 16, 1–15 (2017). · DOI
- Ferreira, M. U. et al. Relative contribution of low-density and asymptomatic infections to Plasmodium vivax transmission in the Amazon: pooled analysis of individual participant data from population-based cross-sectional surveys. Lancet Reg. Health - Am. 9, 100169 (2022).
- Villena, F. E. et al. Drug resistance and population structure of Plasmodium falciparum and Plasmodium vivax in the Peruvian Amazon. Sci. Rep. 12, 1–11 (2022). · DOI
- Kattenberg, J. H. et al. Novel highly-multiplexed AmpliSeq targeted assay for Plasmodium vivax genetic surveillance use cases at multiple geographical scales. Front. Cell Infect. Microbiol. 12, 1–24 (2022). · DOI
- Baniecki, M. L. et al. Development of a single nucleotide polymorphism barcode to genotype Plasmodium vivax infections. PLoS Negl. Trop. Dis. 9, e0003539 (2015). · DOI · Paper page
- Trimarsanto, H. et al. A molecular barcode and web-based data analysis tool to identify imported Plasmodium vivax malaria. Commun. Biol. 5, 1–10 (2022). · DOI · Paper page
- Fola, A. A. et al. SNP barcodes provide higher resolution than microsatellite markers to measure Plasmodium vivax population genetics. Malar. J. 19, 375 (2020). · DOI
- Aydemir, O. et al. Drug-resistance and population structure of Plasmodium falciparum across the Democratic Republic of Congo using high-throughput molecular inversion probes. J. Infect. Dis. 218, 946–955 (2018). · DOI · Paper page
- Taylor, A. R., Jacob, P. E., Neafsey, D. E. & Buckee, C. O. Estimating relatedness between malaria parasites. Genetics 212, 1337–1351 (2019). · DOI · Paper page
- Delgado-Ratto, C. et al. Population genetics of Plasmodium vivax in the Peruvian Amazon. PLoS Negl. Trop. Dis. 10, e0004376 (2016). · DOI
- Delgado-Ratto, C. et al. Population structure and spatio-temporal transmission dynamics of Plasmodium vivax after radical cure treatment in a rural village of the Peruvian Amazon. Malar. J. 13, 1–12 (2014). · doi:10.1186/1475-2875-13-8
- Manrique, P. et al. Microsatellite analysis reveals connectivity among geographically distant transmission zones of Plasmodium vivax in the Peruvian Amazon: a critical barrier to regional malaria elimination. PLoS Negl. Trop. Dis. 13, e0007876 (2019). · DOI
- Roesch, C. et al. Genetic diversity in two Plasmodium vivax protein ligands for reticulocyte invasion. PLoS Negl. Trop. Dis. 12, e0006555 (2018). · DOI
- Kosaisavee, V. et al. Genetic diversity in new members of the reticulocyte binding protein family in Thai Plasmodium vivax isolates. PLoS One 7, 1–6 (2012). · DOI
- Chan, L.-J. et al. Plasmodium vivax reticulocyte binding proteins for invasion into reticulocytes. Cell Microbiol 22, e13110 (2020). · DOI
- Han, J. H. et al. Identification of a reticulocyte-specific binding domain of Plasmodium vivax reticulocyte-binding protein 1 that is homologous to the PfRh4 erythrocyte-binding domain. Sci. Rep. 6, 1–12 (2016). · DOI · Paper page
- Gupta, E. D. et al. Naturally acquired human antibodies against reticulocyte-binding domains of Plasmodium vivax proteins, PvRBP2c and PvRBP1a, exhibit binding-inhibitory activity. J. Infect. Dis. 215, 1558–1568 (2017). · doi:10.1093/infdis/jix170
- Nourani, L., Abouie, A., Id, M., Zakeri, S. & Djadid, N. D. Untangling population structure and genetic diversity of reticulocyte binding protein 2b (PvRBP2b) erythrocytic stage vaccine candidate in worldwide Plasmodium vivax isolates. https://doi.org/10.1371/journal.pone.0266067 (2022). · DOI
- Núñez, A., Ntumngia, F. B., Guerra, Y., Adams, J. H. & Sáenz, F. E. Genetic diversity and natural selection of Plasmodium vivax reticulocyte invasion genes in Ecuador. Malar. J. 22, 1–17 (2023). · DOI
- de Sousa, T. N., Kano, F. S., de Brito, C. F. A. & Carvalho, L. H. The Duffy binding protein as a key target for a Plasmodium vivax vaccine: lessons from the Brazilian Amazon. Mem. Inst. Oswaldo Cruz 109, 608–617 (2014). · DOI
- Menard, D. et al. Whole genome sequencing of field isolates reveals a common duplication of the duffy binding protein gene in Malagasy Plasmodium vivax strains. PLoS Negl. Trop. Dis. 7, e2489 (2013). · doi:10.1371/journal.pntd.0002489
- Hostetler, J. B. et al. Independent origin and global distribution of distinct Plasmodium vivax duffy binding protein gene duplications. PLoS Negl. Trop. Dis. 10, e0005091 (2016). · DOI
- Sá, J. M. et al. Plasmodium vivax chloroquine resistance links to pvcrt transcription in a genetic cross. Nat. Commun. 10, 1–10 (2019). · DOI
- Villena, F. E. et al. Molecular surveillance of the Plasmodium vivax multidrug resistance 1 gene in Peru between 2006 and 2015. Malar. J. 19, 1–10 (2020). · DOI
- Marfurt, J. et al. Molecular markers of in vivo plasmodium vivax resistance to amodiaquine plus sulfadoxine-pyrimethamine: mutations in pvdhfr and pvmdr1. J. Infect. Dis. 198, 409–417 (2008). · doi:10.1086/589882
- Auliff, A. et al. Amino acid mutations in Plasmodium vivax DHFR and DHPS from several geographical regions and susceptibility to antifolate drugs. Am. J. Trop. Med. Hyg. 75, 617–621 (2006). · DOI
- Imwong, M. et al. Association of genetic mutations in Plasmodium vivax dhfr with resistance to sulfadoxine-pyrimethamine: geographical and clinical correlates. Antimicrob. Agents Chemother. 45, 3122–3127 (2001). · DOI
- Khim, N. et al. Effects of mefloquine use on plasmodium vivax multidrug resistance. Emerg. Infect. Dis. 20, 1637–1644 (2014). · DOI
- Li, J. et al. Ex vivo susceptibilities of Plasmodium vivax isolates from the China-Myanmar border to antimalarial drugs and association with polymorphisms in Pvmdr1 and Pvcrt-o genes. PLoS Negl. Trop. Dis. 14, e0008255 (2020). · DOI · Paper page
- Ruebush, T. K., Neyra, D. & Cabezas, C. Modifying national malaria treatment policies in Peru. J. Public Health Policy 25, 328–345 (2004). · DOI
- Popkin-Hall, Z. R., et al. “Study Participant Data”, https://doi.org/10.15139/S3/H0YPJD, UNC Dataverse, V1, UNF:6:QRA39Ul896HR5EbqEG50MA = = [fileUNF] (2024). · doi:10.15139/s3/h0ypjd
- Knaus, B. J. & Grünwald, N. J. vcfr: a package to manipulate and visualize variant call format data in R. Mol. Ecol. Resour. 17, 44–53 (2017). · DOI · Paper page
- Danecek, P. et al. Twelve years of SAMtools and BCFtools. Gigascience 10, 1–4 (2021). · DOI · Paper page
- Chang, H.-H. et al. THE REAL McCOIL: a method for the concurrent estimation of the complexity of infection and SNP allele frequency for malaria parasites. PLoS Comput Biol. 13, e1005348 (2017). · DOI
- Ferreira, I. D., Rosário, V. Edo & Cravo, P. V. L. Real-time quantitative PCR with SYBR Green I detection for estimating copy numbers of nine drug resistance candidate genes in Plasmodium falciparum. Malar. J. 5, 1 (2006). · DOI · Paper page
- Srisutham, S., Suwannasin, K., Sugaram, R., Dondorp, A. M. & Imwong, M. Measurement of gene amplifications related to drug resistance in Plasmodium falciparum using droplet digital PCR. Malar. J. 20, 1–12 (2021). · DOI
- Tumwebaze, P. K. et al. Drug susceptibility of Plasmodium falciparum in eastern Uganda: a longitudinal phenotypic and genotypic study. Lancet Microbe 2, e441–e449 (2021). · DOI
- MalariaGEN et al. An open dataset of Plasmodium vivax genome variation in 1895 worldwide samples. Wellcome Open Res. 7, 136 (2022). · DOI · Paper page
Cited by
Osborne, A. A., Ruybal-Pesantez, S., Rai, A., Trimarsanto, H., Hoon, K. S., Piera, K., Kleinecke, M., Rumaseb, A., Sutanto, E., Thriemer, K., et al. (2026) · doi:10.64898/2026.11.12.765293
Metadata
- Authors
- Popkin-Hall, Z. R., Niaré, K., Crudale, R., Simkin, A., Fola, A. A., Sanchez, J. F., Pannebaker, D. L., Giesbrecht, D. J., Kim, I. E., Aydemir, Ö., Bailey, J. A., Valdivia, H. O., & Juliano, J. J.
- ORCID
- Venue
- Nature Communications
- Published
- 2024-11-25
- Volume
- 15
- Issue
- 1
- ISSN
- 2041-1723
- Cited by
- 11
- References
- 4
- Language
- en
- Licence
- creativecommons.org/licenses/by-nc-nd/4.0 (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0 (vor)
- Funders
- U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (R01AI165537, R01TW010870)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: High-throughput genotyping of Plasmodium vivax in the Peruvian Amazon via molecular inversion probes. https://app.cochat.ai/papers/10.1038/s41467-024-54731-y
- The paper
- Popkin-Hall, Z. R., Niaré, K., Crudale, R., Simkin, A., Fola, A. A., Sanchez, J. F., Pannebaker, D. L., Giesbrecht, D. J., Kim, I. E., Aydemir, Ö., Bailey, J. A., Valdivia, H. O., & Juliano, J. J. (2024). High-throughput genotyping of Plasmodium vivax in the Peruvian Amazon via molecular inversion probes. Nature Communications. https://doi.org/10.1038/s41467-024-54731-y
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.